503A · CompoundedIllustration only. Actual medication will vary.Longevity · Growth hormone–releasing peptide
Sermorelin
A peptide that signals the body’s own growth hormone release. Available as a nightly injection or a dissolvable tablet.
Your Plan Options
Injection 0.9 mg/mL
10 mL vial · 30-day supply
$259 /mo
Injection 0.9 mg/mL
10 mL vial · 90-day supply
$709 /3 mo
Best value
2 mg ODT
30 tabs/mo · 30-day supply
$239 /mo
2 mg ODT
30 tabs/mo · 90-day supply
$649 /3 mo
Best value
5 mg ODT
30 tabs/mo · 30-day supply
$339 /mo
5 mg ODT
30 tabs/mo · 90-day supply
$899 /3 mo
Best value
No charge until a provider prescribes. Prescription required.
Clinical information
What this is, in plain language.
Sermorelin is a growth hormone–releasing hormone (GHRH) analog that prompts the pituitary to release growth hormone. It is prepared by a licensed 503A compounding pharmacy and dispensed only when a licensed provider determines it is clinically appropriate.
Active ingredients
Sermorelin 0.9 mg/mL injection, or 2 mg / 5 mg ODT.
Mechanism
GHRH analog that stimulates the body’s own growth hormone release.
Administration
Subcutaneous injection or dissolvable tablet, usually at bedtime, as directed by your prescriber.
Who it is for
Adults evaluating growth hormone–related support, when clinically appropriate.
Common effects
Injection-site reactions, flushing, headache. Discuss full risks with your provider.
Important safety & compliance information
Compounded sermorelin is not FDA-approved. It is prepared by a licensed 503A compounding pharmacy and is descriptive only — it is not a branded drug. Product imagery shown here is illustration only; actual medication is dispensed in a pharmacy-labeled container and will vary in appearance. A prescription is required and is issued only when a licensed provider determines treatment is clinically appropriate. This page is not medical advice. Discuss benefits, risks and side effects with your provider.